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In Brief
Improved therapy for neuropathic pain
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spinal cord neuronal networks that
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Neuropathic pain is a chronic debilitating disease
that results from nerve damage, persists long after
the injury has subsided, and is characterized by
spontaneous pain and mechanical hypersensitivity.
Although loss of inhibitory tone in the dorsal horn of
the spinal cord is a major contributor to neuropathic
pain, the molecular and cellular mechanisms under-
lying this disinhibition are unclear. Here, we com-
bined pharmacogenetic activation and selective
ablation approaches in mice to define the contribu-
tion of spinal cord parvalbumin (PV)-expressing
inhibitory interneurons in naive and neuropathic
pain conditions. Ablating PV neurons in naive mice
produce neuropathic pain-like mechanical allodynia
via disinhibition of PKCg excitatory interneurons.
Conversely, activating PV neurons in nerve-injured
mice alleviates mechanical hypersensitivity. These
findings indicate that PV interneurons are modality-
specific filters that gate mechanical but not thermal
inputs to the dorsal horn and that increasing PV inter-
neuron activity can ameliorate themechanical hyper-
sensitivity that develops following nerve injury.
INTRODUCTION
Neuropathic pain is a chronic debilitating disease that follows
nerve injury, persists long after the initial injury has subsided,
and decreases the quality of life of the patients (Jensen et al.,
2007). Despite a plethora of medications and treatment modal-
ities, new treatment approaches for neuropathic pain are
needed. Two hallmarks of neuropathic pain are spontaneous1246 Cell Reports 13, 1246–1257, November 10, 2015 ª2015 The Aupain and mechanical allodynia, a painful response to an innoc-
uous stimulus, such as gentle touch. These symptoms are due
in part to a spinal cord dysfunction characterized by decreased
inhibitory controls (Castro-Lopes et al., 1993; Moore et al., 2002;
Lever et al., 2003; Coull et al., 2003). Enhancing inhibition by acti-
vating spinal GABA receptors is effective in some animal models
of chronic pain, but the use of GABA agonists in patients is
limited due to lack of efficacy and/or adverse side effects (Munro
et al., 2009). These shortcomings are due in part to our limited
understanding of the neuronal circuitry through which the loss
of inhibitory control is manifested (Braz et al., 2014).
Particularly relevant to this question is that touch-sensitive
Ab primary afferent fibers can access spinal cord nociceptive
(pain) circuits through polysynaptic pathways (Torsney and
MacDermott, 2006). Under normal conditions, these pathways
are under tonic inhibition, likely derived from glycinergic inter-
neurons located in deeper laminae (Takazawa and MacDermott,
2010). However, in the setting of nerve injury, this inhibitory input
is reduced, thereby enabling Ab fiber-transmitted innocuous
inputs to engage and activate nociceptive pathways (Torsney
and MacDermott, 2006); see Figure 1. The particular circuits
that are disinhibited and whether the disinhibition involves the
death of inhibitory interneurons are not clear (Polga´r and Todd,
2008).
Here, we used genetic and functional approaches to examine
the contribution of parvalbumin (PV)-expressing inhibitory inter-
neurons as gate-keepers of the touch-pain circuitry in the dorsal
horn. The location of these interneurons at the border between
inner lamina II (IIi) and III is ideal for the modulation of mechanical
inputs derived frommyelinated primary afferent fibers. However,
there is currently nothing known about their contribution to the
processing of sensory information in the dorsal horn.
We report that PV interneurons act as modality-specific filters
of sensory inputs in the dorsal horn. Increasing their activity
significantly alleviates themechanical allodynia in amousemodelthors
Figure 1. Spinal Lamina I Output Neurons
Do Not Receive Direct Input from Low-
Threshold Ab Primary Afferents
Yet a polysynaptic pathway links myelinated
Ab fibers to lamina I neurons (Torsney and
MacDermott, 2006). Under normal conditions (left
panel), the link is repressed by inhibitory glyci-
nergic interneurons (red, left panel). After nerve
injury (right panel), impaired inhibition unmasks the
connection, thus enabling low-threshold inputs to
drive lamina I projection neurons. Yellow high-
lighting indicates flow of information. Adapted
from Prescott et al. (2014).of neuropathic pain. Conversely, selective ablation or silencing of
PV interneurons induces mechanical allodynia in naive mice.
Using electron microscopy, we identified synaptic contacts
between PV+ terminals and PKCg+ excitatory interneurons.
Nerve injury or ablation of PV neurons results in a significant
decrease in the number of these contacts, which disinhibits
PKCg interneurons and leads to mechanical allodynia. Inhibition
of PKCg interneurons attenuates mechanical allodynia in both
conditions.
RESULTS
Parvalbumin Interneurons Do Not Die after Nerve Injury
It has been suggested that nerve-injury-mediated disinhibition in
the dorsal horn is due to the degeneration of GABAergic inhibi-
tory interneurons (Scholz et al., 2005). Although this claim has
been challenged (Polga´r et al., 2004), we reexamined the ques-
tion, focusing specifically on the survival of PV interneurons in
the spared nerve injury (SNI) model of neuropathic pain (Shields
et al., 2003). Because loss of PV immunostaining following nerve
injury does not necessarily indicate loss of PV+ neurons, we
examined a marker that is independent of PV expression. To
this end, we crossed a transgenic Parvalbumin::Cre (PV::cre)
knockin mouse to a tdTomato (tdTom, red fluorescent protein)
reporter mouse. In PV::cre; tdTom mice, tdTom is expressed in
the cytosol and processes of PV neurons of the adult spinal
cord, independently of the expression level of PV.
Given that the expression pattern of certain markers can
change during development (Cavanaugh et al., 2011a), we first
asked whether tdTom-expressing cells correspond to the PV-
immunoreactive (IR) neurons in the adult. Our experiments (Fig-
ures 2A–2C) indicate that 83.7% ± 3.0% of the PV-IR neurons
are tdTom positive, and all tdTom-positive neurons are positive
for PV-IR. Thus, the expression of tdTom recapitulated the
endogenous PV expression, and importantly there is no ectopic
expression of tdTom in the spinal cord of the PV::cre; tdTom
mice. Two previous reports indicated that, in the rat dorsal
horn, not all PV-IR neurons are inhibitory (Antal et al., 1991; Laing
et al., 1994). To address this question, we stained dorsal horn
sections of PV::cre; tdTom mice with a mixture of GABA andCell Reports 13, 1246–1257, Noglycine antibodies and demonstrate that
95.4% of tdTom-expressing neurons are
GABA and/or glycinergic (Figure 2D).
Furthermore, we observed less than 5%colocalization with Lmx1b (Figure 2E) or Tlx3 (four of 79 neurons,
n = 2 mice, data not shown), two transcription factors expressed
in excitatory interneurons (Szabo et al., 2015; Foster et al., 2015).
We next determined whether PV neurons die after nerve injury. In
agreement with previous studies (Huang et al., 2010; Polga´r
et al., 2013a; Yamamoto et al., 1989), we observed that the dor-
sal horn of naive mice contains 12.3 ± 3.4 PV neurons on each
side of a 25-mm-thick transverse section. Our results indicate,
however, that there is no loss of tdTom+ (i.e., PV) neurons
between naive, sham, or nerve-injured mice, 3, 5, or 8 weeks
post-nerve injury (Figures 2F and 2G). Given that 16% of PV-
immunoreactive neurons were negative for tdTom expression,
it is not possible to know what happens to these neurons after
SNI. However, staining with an anti-activated caspase 3 anti-
body failed to show any evidence of apoptosis in dorsal horns
of nerve-injured mice 1, 3, and 8 weeks post injury (data not
shown). We conclude that there is no significant loss of PV inter-
neurons in the SNI model of neuropathic pain.
Pharmacogenetic Activation of PV Interneurons Reveals
Their Modality-Specific Filtering of Sensory Inputs
Although Celio and Heizmann described PV interneurons in the
dorsal horn over 30 years ago (Celio and Heizmann, 1981), little
is known about their contribution to the processing of sensory in-
puts. Reports monitoring Fos expression found that PV neurons
are not activated by peripheral noxious stimuli (Polga´r et al.,
2013a; Neumann et al., 2008). Furthermore, approximately
50% of the nerve terminals of large diameter fibers (Hughes
et al., 2012), presumably of the Ab type, receive inputs from
PV+ profiles in the spinal cord, which suggests that they may
regulate the processing of innocuous inputs. To assess the func-
tion of dorsal horn PV interneurons, we modulated their activity
using a pharmacogenetic approach (Alexander et al., 2009;
Rogan and Roth, 2011; Dong et al., 2010). This approach uses
a modified Gq-coupled muscarinic receptor (M3D) that only
responds to an exogenous, blood-brain-barrier-permeable, syn-
thetic agonist: clozapine N-oxide (CNO) (Figure S1). CNO activa-
tion of cultured dorsal horn neurons infected with M3D induces
membrane depolarization (8.3 ± 3 mV) and generates action po-
tentials in PV interneurons (Figure S1D) (Alexander et al., 2009).vember 10, 2015 ª2015 The Authors 1247
Figure 2. PV::cre; tdTomato Transgenic Mice Recapitulate Endogenous PV Expression
(A) Transgenic PV::cre; tdTomato mice express tdTom (red) exclusively in PV (green)-expressing interneurons. Scale bar, 150 mm.
(B and C) The vast majority of PV-immunoreactive (IR) neurons (84%; 142 out 168 neurons, n = 3) express tdTom, and all tdTom+ neurons (142/142) express PV.
Scale bar, 30 mm.
(D) Top panels: transverse section of the dorsal horn stained with GABA and glycine antibodies (green) and Nissl (blue). Bottom panels: magnification of top
panels. The majority of TdTom-positive PV neurons (95%; 419 of 439 neurons, n = 5 mice) express GABA and/or glycine.
(E) Top panels: transverse section of the dorsal horn stained with an Lmx1b antibody (green). Bottom panels: magnification of top panels. The majority of
PV neurons are Lmx1b negative (62 of 65 neurons, n = 2 mice).
(F) Composite image showing the presence of PV neurons 8 weeks after SNI. Scale bar, 150 mm.
(G) Number of PV interneurons (ratio of ipsi/contra) at different time points after nerve injury. N, naive (n = 5); S, sham-operated (n = 5); 3, 5, and 8, the number of
weeks post nerve injury, with n = 5, 7, and 8, respectively.
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Figure 3. Activation of PV Interneurons
Elevates Mechanical Thresholds without
Affecting Thermal Sensitivity in Awake
Naive and Neuropathic Mice
(A) Activation of PV neurons in naive mice
(CNO 5 mg/kg; i.p) significantly increases me-
chanical withdrawal thresholds (n = 12) ipsilateral
to the AAV-M3D injection side. Lower doses of
CNOhad no effect. *Significant difference from the
saline-injected group.
(B) Activation of PV neurons has no effect on
thermal withdrawal latency (n = 12).
(C) CNO-injected mice perform as well as saline-
injected mice in the rotarod test (n = 3), indicating
that 5 mg/kg CNO does not cause any motor
impairment.
(D) Peripheral nerve injury (SNI) causes a leftward
shift in the behavioral responses to mechanical
stimulation (from blue to red curve), indicating
mechanical allodynia (see inset). Activation of PV
neurons (CNO 3 mg/kg) 20 min prior to testing
attenuates the allodynia (green arrow in inset).
(E) Injection of CNO in nerve-injured PV::cre;
tdTomato mice infected with AAV-M3D signifi-
cantly attenuates the mechanical allodynia (left
panel). No anti-allodynic effects were observed
with a control AAV (mCit alone). Mechanical
thresholds were recorded before and after
systemic administration of CNO. N, naive;
p, nerve-injured mice, baseline; S, saline injected,
nerve-injured mice; 1, 3, and 5, doses of CNO in
mg/kg (n = 8–10 mice per group). *,**Significant
difference from the saline-injected group.
(F) Activation of PV interneurons modulates me-
chanical thresholds without affecting thermal
sensitivity in an inflammatory pain model. Subcu-
taneous injection of capsaicin into the heel of
the hindpaw induces a significant reduction of
mechanical threshold (left panel) (9.4% ± 2.3%,
n = 4, gray bar) that is attenuated following
administration of CNO (5 mg/kg; i.p.) in AAV-
M3D-injected PV::cre; mice (42.2% ± 16.7%,
n = 4, black bar) ipsilateral to the AAV injection
side. The capsaicin injection also produces a
significant reduction of thermal withdrawal
thresholds (right panel) (4.86 ± 0.71 sec, n = 4,
gray bar) compared to baseline values (7.41 ±
0.61 sec, n = 4, white bar). CNO administration had no effect on thermal withdrawal thresholds, demonstrating the modality-specific PV interneuron-mediated
inhibition in this model (4.09 ± 0.39 sec, n = 4, gray bar). *Significant difference between groups compared, following a Kruskal-Wallis ANOVA on ranks with
multiple comparisons (Student-Newman-Keuls Method). NS, non-significant; i.p., intraperitoneal.To activate PV neurons in vivo, we injected the lumbar spinal
cord of PV::cre; tdTom mice with an adeno-associated viral
(AAV) vector expressing Cre-dependent M3D and the reporter
mCitrine (mCit). Although a subset of peripheral sensory neurons
also expresses PV, we did not observe any M3D expression
in dorsal root ganglia (DRG) (data not shown). Figure 3A shows
that activation of PV neurons significantly increased baseline
mechanical withdrawal thresholds compared to saline-injected
mice (1.86 ± 0.30 versus 1.27 ± 0.10 g), without affecting thermal
withdrawal latencies (Figure 3B). Furthermore, CNO injection
had no effect on mechanical withdrawal thresholds in control
virus (mCit alone)-injected PV::cre; tdTom mice (baseline:
1.35 ± 0.37; 5mg/kg CNO: 1.16 ± 0.26 g; data not shown). A sub-Cell Repset of ventral horn interneurons expresses parvalbumin (Antal
et al., 1990). To exclude their potential activation by CNO, we
examined mice injected with the highest dose of CNO on the
rotarod test. We found no motor impairment in these mice (Fig-
ure 3C). Taken together, our results indicate that dorsal horn
PV interneurons function as modality-specific filters of somato-
sensory information.
PV Neuron Activation Reduces Nerve-Injury-Induced
Mechanical Hypersensitivity
There is no evidence for a direct projection of large diameter, Ab
afferents to pain-transmitting projection neurons of lamina I. In a
model of neuropathic pain, however, Ab fiber stimulation evokesorts 13, 1246–1257, November 10, 2015 ª2015 The Authors 1249
Figure 4. Appositions between PV+ Termi-
nals and Lamina IIi PKCg-Expressing Inter-
neurons
(A) tdTom+ interneurons (magenta) are located in
thevicinity of excitatoryPKCg (green) interneurons.
(B) Panels: (1) Maximal projection of a decon-
volved z stack of confocal images taken at the
0.1-mm interval and then processed through the
Imaris software to define surface rendering (2) of
the tdTom profiles surrounding the PKCg soma.
(3) Areas of tdTom signals on the PKCg surface
and of PKCg signal on tdTom surface (4). The
‘‘spot co-localization’’ feature identifies areas
positive for both PKCg and tdTom. This process
defines the number of appositions of tdTom
terminals on PKCg soma, as co-incident locali-
zations (white arrows), and excludes unspecific
detections, as PKCg spots distant from tdTom
processes (yellow arrowhead) or tdTom spots
distant from the PKCg soma (red arrowhead).
Scale bar, 10 mm.
(C) Mean (±SEM) proportion (%) of PKCg somata
in relation to the number of PV appositions (n = 64
somata from six mice).polysynaptic excitation of these projection neurons, an effect
that can be reproduced by intracisternal administration of the
glycine receptor antagonist, strychnine (Miraucourt et al.,
2007). These findings suggest that loss of glycinergic inhibitory
inputs contributes to the mechanical allodynia following nerve
injury. In fact, PV interneurons co-express GABA and glycine (La-
ing et al., 1994) and are activated by Ab fibers (Hughes et al.,
2012). Nevertheless, the consequence of decreased function
of PV interneurons to mechanical allodynia in neuropathic pain
models remains unknown. Here, we asked whether increasing
the activity of PV interneurons with CNO can attenuate mechan-
ical allodynia in the setting of nerve injury. We performed these
studies in mice that received a unilateral injection of the Cre-
dependent AAV-M3D 21 days prior to nerve injury.
Figures 3D and 3Edemonstrates that activation of PV interneu-
rons ipsilateral to the nerve injury significantly and dose-depen-
dently attenuates the mechanical allodynia (0.58 ± 0.08 g in
saline-injected versus 1.00 ± 0.12 g in CNO (3 mg/kg)-injected
mice). However, CNO had no effect on mechanical allodynia in
control virus-injected PV::cre; tdTom mice (0.30 ± 0.04 g in
saline-injected versus 0.29 ± 0.17 g in CNO 3 mg/kg-injected
mice). To determine whether this attenuation is selective for me-
chanical inputs, we used an inflammatory pain model associated
with both mechanical allodynia and thermal hyperalgesia (Bonin
and De Koninck, 2014). In this model, activation of PV interneu-
rons selectively attenuated the mechanical allodynia without
affecting the thermal hyperalgesia (Figure 3F). We conclude that
increasing the activity of PV interneurons selectively attenuates
mechanical allodynia without affecting thermal hypersensitivity.
Parvalbumin Interneurons Target Excitatory PKCg
Interneurons
Activity of PKCg excitatory interneurons is essential to the devel-
opment of mechanical allodynia after nerve injury (Miraucourt1250 Cell Reports 13, 1246–1257, November 10, 2015 ª2015 The Auet al., 2007; Malmberg et al., 1997). In normal conditions, these
neurons are under tonic, strychnine-sensitive (Miraucourt et al.,
2007, 2009), glycinergic (Lu et al., 2013) inhibition, which pre-
vents the induction of mechanical allodynia (Miraucourt et al.,
2007). To determine whether PV interneurons are anatomically
positioned to modulate the activity of PKCg interneurons, we
examined the presence of appositions between the terminals
of PV interneurons, which express tdTom, and the cell bodies
of PKCg-IR interneurons, which predominate in inner lamina II.
Consistent with this hypothesis, we recorded a significant num-
ber of PV+ terminals (3.87 ± 0.41 appositions per PKCg soma,
n = 64 neurons from six mice; Figures 4A–4C). Because a subset
of large-diameter sensory afferents express PV (Ernfors et al.,
1994; Antal et al., 1990), it is possible that they contribute to
the tdTom-positive appositions onto PKCg interneurons instead
of or in addition to the dorsal horn PV interneurons. To evaluate
this possibility, we performed double immunohistochemical ex-
periments to determine whether the tdTom-positive terminals
colocalize with the vesicular glutamate transporter-1 (VGluT1),
a marker of large-diameter myelinated sensory neurons (Hughes
et al., 2012). We found that only 0.2% ± 0.1% of the VGluT1-pos-
itive terminals colocalized with tdTom in the dorsal horn lamina IIi
and III, where the PV and PKCg interneurons are found (Figures
S2A and S2B).
Sensory neurons that express PV are mainly proprioceptors,
with axons terminating in deeper laminae of the spinal cord,
mainly lamina IX (Zampieri et al., 2014). Not surprisingly, when
we examined the colocalization of VGluT1+ terminals with tdTom
in lamina IX, we observed a significantly larger percentage of co-
localization (55.6% ± 15.7%) than in laminae IIi-III. Additionally,
we failed to see any colocalized VGluT1+/tdTom+ terminals on
the surface of PKCg interneurons (Figure S2D). We conclude
that the tdTom signal detected on PKCg interneurons does not
originate from peripheral sensory neurons.thors
Figure 5. Inhibitory Nature of the Synaptic
Connection between PV and PKCg Inter-
neurons
(A) Confocal picture from the lamina IIi of the
dorsal horn displaying PKCg neurons (green), PV
neurons’ processes (red), and in magenta: VAMP2
(top panel), GlyT2 (middle panel), or gephyrin
(bottom panel). Arrowheads in top and middle
panel, colocalization of the tdTom and VAMP2
or GlyT2 signals. Bottom panel, apposition of
the TdTom and gephyrin signals. Scale bar of
insets, 2 mm.
(B) Mean (±SEM) appositions per PKCg neuron
soma is not significantly different (Kruskal-Wallis
test) in tdTom+ alone (3.87 ± 0.41; white bar; n = 64
somata, six mice) compared to tdTom+ colo-
calized with VAMP2 (3.31 ± 0.86; hatched bar;
n = 10 somata, two mice) or tdTom+ colocalized
with GlyT2 (4.03 ± 0.64; gray bar; n = 13 somata,
three mice) or tdTom+ facing gephyrin clusters
(2.51 ± 0.45; black bar; n = 10 somata, two mice).
(C) Electron micrographs of lamina IIi of the dorsal
horn of a PV::cre; tdTomato mouse showing the
association between PKCg-IR dendrites (d; note
silver-gold particles) and tdTom-IR boutons (note
dense precipitate) indicated by arrows; note the
presence a symmetric synapse (arrowheads)
between the tdTom-IR boutons and the PKCg-IR
dendrites (d); b: unlabeled bouton.To investigate the nature of the appositions, including whether
they expressed specific synaptic markers, we immunostained
dorsal horn sections from PV::cre; tdTom mice for PKCg and
(1) VAMP2 or (2) GlyT2, a presynaptic and an inhibitory presyn-
aptic marker, respectively (Figure 5A). We found significant co-
incident localization of tdTom+ appositions with VAMP2 and
GlyT2 (Figure 5B). We confirmed the inhibitory nature of the
tdTom apposition by staining for gephyrin, a postsynaptic
marker of inhibitory synapses (Majdi et al., 2007). Our data
demonstrate that the terminals of PV neurons appose gephyrin
clusters on the soma of PKCg neurons (Figures 5A and 5B).
The average number of appositions per PKCg soma was similar
in all three conditions compared to the situation without synaptic
marker (Figure 5B), confirming that these are glycinergic
appositions.
To determine whether the appositions constitute functional
synapses, we performed electron microscopy on the dorsalCell Reports 13, 1246–1257, Nohorn of naive PV::cre; tdTommice, immu-
nostained for tdTomato and PKCg. In
inner lamina II, we observed tdTom-IR
dendrites and boutons (Figure 5C).
PKCg-IR dendrites and somata occurred
in the same layer. The tdTom-IR boutons
established synapses onto PKCg-IR
dendrites (Figure 5C). The boutons con-
tained pleomorphic vesicles, and the
synapses were of the symmetric type,
suggestive of inhibitory contacts. As
shown in the rat (Peirs et al., 2014),
PKCg labeling was located at the plasmamembrane and in the cytoplasm of neurons. Our results there-
fore indicate that the PKCg subset of excitatory interneurons is
a target of the PV interneurons.
Nerve Injury Induces a Detachment of PV Interneuron
Processes, which Disinhibits PKCg Interneurons
We hypothesize that a decrease in the function of PV interneu-
rons can lead to a disinhibition of the PKCg interneurons. To
determine whether this reduction is caused by a detachment
of PV nerve terminals from PKCg somata, we examined the con-
nections between these two interneurons subtypes in naive and
nerve-injuredmice. Our data demonstrate that themean number
of PV appositions on PKCg somata is significantly lower in nerve-
injured compared to naive mice (Figure 6A). There is a redistribu-
tion of the number of appositions on PKCg somata (Figures 6B
and 6C), with the median shifting from 3.28 appositions in naive
to 1.84 in nerve-injured mice.vember 10, 2015 ª2015 The Authors 1251
Figure 6. Nerve Injury Induces a Detach-
ment of PV-PKCg Appositions that Disin-
hibits PKCg Interneurons
(A) The mean (±SEM) number of somatic
appositions is significantly lower in nerve-injured
(SNI) compared to naive mice (3.87 ± 0.41 in
naive mice; n = 64 somata from six mice versus
2.63 ± 0.31 in nerve-injured mice; n = 54 somata
from three mice; *p = 0,037; t test for unpaired
data).
(B) Mean (±SEM) proportion (%) of PKCg
somata in relation to the number of PV
appositions. (*p < 0.05, ***p < 0.001; test of inde-
pendence in contingency table, Fisher’s exact
probability).
(C) Conversion of data in (B) into cumulative pro-
portion demonstrates a leftward shift of the fit after
nerve injury (SNI) (***p < 0.001, Kolmogorov and
Smirnov test).
(D) Inhibition of PKCg activity reduces mechanical
allodynia produced after SNI. Naive mice were
tested before (double minus) and 20–30 min after
intrathecal (i.t.) injection of 100 pmol of gV5-3. The
PKCg inhibitor and its control (TAT peptide) were
then tested on nerve-injured mice. *,***Significant
difference compared to naive baseline (n = 8).
ySignificant effect of gV5-3 treatment compared to
SNI baseline (n = 7), Wilcoxon signed-rank test for
paired data.
(E) Representative images of brush-induced Fos
expression in the dorsal horn of a nerve-injured
mouse pretreated i.t. with TAT (upper panel) or
gV5-3 (lower panel). Scale bar, 100 mm; roman
numbers indicate lamina.
(F) Mean (±SEM) number of Fos-IR neurons per
25-mm section. In nerve-injured mice pretreated
i.t. with TAT (n = 3), gentle brushing evoked Fos induction in neurons of laminae I–III ipsilateral to the nerve injury. In nerve-injured mice pretreated with gV5-3,
brush-evoked FOS induction is significantly lower (n = 3). ***Significant difference between the TAT and the gV5-3 groups. Mann-Whitney test.We hypothesized that if this loss of PV interneurons inputs
enables PKCg interneurons to drive mechanical allodynia
after nerve injury, then blocking the activity of the
PKCg interneurons should attenuate the allodynia. To test
this possibility, we recorded the mechanical thresholds
of naive and nerve-injured mice after intrathecal injection
of the selective PKCg inhibitor gV5-3. Figure 6D shows
that blockade of PKCg has no effect in naive mice
but significantly attenuates the mechanical allodynia in ner-
ve-injured mice. In related studies, we monitored stimulus-
induced Fos expression in the superficial dorsal horn. In
naive mice, gentle brushing of the hindpaw does not
induce Fos expression in neurons of laminae I and III. How-
ever, the same innocuous stimulus induces Fos expression
ipsilateral to a nerve injury; these mice were intrathecally
injected with vehicle (TAT; Figures 6E and 6F). In contrast,
pre-treatment with gV5-3 significantly reduced the number
of activated (Fos-positive) superficial laminae neurons (Fig-
ures 6E and 6F). The anti-allodynic effect of PKCg inhibition
appears to be specific to mechanical inputs as testing
gV5-3 in an inflammatory pain model associated with
mechanical allodynia and thermal hyperalgesia (Bonin and
De Koninck, 2014) attenuated only mechanical allodynia
(Figure S3).1252 Cell Reports 13, 1246–1257, November 10, 2015 ª2015 The AuSelective Ablation of PV Interneurons in Naive Mice
Induces Mechanical Allodynia
The loss of PV neuron-mediated inhibition of PKCg neuron activ-
ity is likely one of many events taking place in the dorsal horn
following nerve injury. To examine the effects of this disinhibition
in isolation from other mechanisms, we ablated PV interneurons
in the dorsal horn of healthy, naive mice. We injected an AAV
expressing Cre-dependent ribosome inactivating protein sap-
orin (Ng et al., 2010) in the dorsal spinal cord of PV::cre; tdTom
mice (Figure S4A). Saporin prevents protein synthesis, which
leads to cell death (Stirpe et al., 1992). We validated the AAV-
Saporin vector in vitro by infecting cultured DRG neurons
obtained from a TRPV1::cre; tdTom mouse and recording
neuronal death over time (Figures S4B and S4C). By 16 days
post infection, we recorded a significant reduction in the number
of tdTom-positive neurons infected with AAV-Saporin compared
to control (culture media) (22.1 ± 7.2 versus 70.6% ± 22.4% of
baseline in saporin and control, respectively; Figure S4B). The
reduction was restricted to Cre-expressing neurons as the
number of neurons immunostained with the neuronal marker
b3-tubulin, and tdTom-negative, did not significantly change
after AAV infection (Figure S4C).
When we injected the AAV-Saporin into the dorsal horn of
PV::cre; tdTom mice, we observed a significant decrease inthors
Figure 7. Saporin-Mediated Ablation of
PV Neurons Induces a PKCg-Dependent
Mechanical Allodynia
(A) Composite image of a dorsal horn section of a
PV::cre; tdTomato mouse injected with AAV-
Saporin (SAP). There is a decrease in the number
of tdTom+ neurons on the ipsilateral side (top-left
panel). No visible decrease in neuronal density is
observed by neuronal staining (left, middle panel).
Control mice were injected with a virus (same titer)
expressing GFP (n = 4). The number of tdTom+
neurons was counted on the ipsilateral and
contralateral sides, and the ratio (±SEM) of ipsi/
contra is plotted (right panel). *p < 0.05, Student’s
t test.
(B) Ablation of PV neurons triggers mechanical
hypersensitivity ipsilateral (black circles) to the
AAV-Saporin injection side. *Significant difference
from contralateral side (white circles, n = 9).
(C) Ablation of PV neurons has no effect on paw
withdrawal latencies in response to noxious ther-
mal stimuli.
(D) The mean (±SEM) number of tdTom+ pro-
cesses apposing PKCg somata is significantly
lower in AAV-Saporin-injected mice (1.87 ± 1.18;
n = 38 somata from five mice) than in control mice
(3.87 ± 0.41; n = 64 somata from six mice) or
in AAV-GFP-injected mice (4.36 ± 0.84; n = 30
somata from three mice). ANOVA (p = 0.013)
with Tukey, all pairwise multiple comparison
(*p < 0.05).
(E) The cumulative proportion of PKCg in-
terneurons with varying numbers of PV apposi-
tions is significantly shifted to the left in
AAV-Saporin-injected mice (p = 4.23 E-5 VS. AAV-
GFP-injected mice; Kolmogorov-Smirnov test).
The proportion of PKCg somata without tdTom+
appositions is significantly higher in AAV-Saporin-
injected mice (38.92% ± 14.6%; n = 38 somata;
five mice) than in control mice (0%; n = 64 somata;
six mice) or in AAV-GFP-injected mice (6.36% ±
3.2%; n = 30 somata; three mice). **p < 0.01 AAV-Saporin- versus AAV-GFP-injected group. Test of independence in contingency table, Fisher’s exact
probability.
(F) Mean (±SEM) number of Fos-IR neurons in laminae I–III per 25-mm-thick spinal cord section. A gentle brushing of the hindpaw induces Fos expression
ipsilateral to AAV-Saporin injection (9.44 ± 0.68 neurons; n = 6). It is not the case in AAV-GFP-injectedmice (0.75 ± 0.25 neurons; n = 3). ***p < 0.001 AAV-Saporin-
versus AAV-GFP-injected group, Mann-Whitney test.
(G) Mean (±SEM) mechanical withdrawal threshold, expressed as percentage of baseline (white bar). Mice were tested before and 30 min after i.t. injection of
100 pmol of either gV5-3 (n = 6) or the TAT peptide (n = 3). *p < 0.05; Friedman repeated-measures ANOVA on ranks with Tukey’s post hoc test.the number of PV interneurons ipsilateral to the injection (ratio
ipsi/contra: 0.55 ± 0.08) 21 days post-infection. On the other
hand, a GFP-expressing virus had no effect on PV interneurons
number (ratio: 0.98 ± 0.08; Figure 7A, right panel). No other
visible neuronal loss was observed, as assessed by neuronal
staining (215.1 ± 1.1 neurons ipsilateral to the saporin injection
compared to 211.2 ± 0.6 neurons contralateral to the saporin
injection, Figure 7A). Because proprioceptor neurons also
express PV (Zampieri et al., 2014), we also examined the ipsilat-
eral and contralateral L3-L4 DRGs from the AAV-Saporin-treated
mice. We found no loss of PV-positive DRG neurons after injec-
tion of saporin in the dorsal horn (Figures S5A and S5B), indi-
cating that the loss of tdTom-positive neurons was restricted
to the dorsal horn. Most importantly, the selective loss of PV
interneurons was associated with a gradual development ofCell Repmechanical allodynia ipsilateral to the injected side (Figure 7B),
with no change in the sensitivity to thermal (heat) stimuli (Fig-
ure 7C). This modality-specific sensitization was reproduced in
PV::cre; tdTom mice that had received an intra-spinal injection
of a silencing DREADD (hM4D), which couples to inhibitory
G proteins (Figure S5C). These results further confirm themodal-
ity-specific filtering function of PV interneurons.
Mechanical Allodynia following PV Interneuron Ablation
Occurs via a PKCg-Dependent Mechanism
Our findings indicate that the PKCg subset of excitatory inter-
neurons is a target of PV interneurons. The kinase activity of
PKCg, by enhancing excitatory (Lan et al., 2001; Lin et al.,
2006) and reducing inhibitory (Yan and Surmeier, 1997; Deng
et al., 2009) transmission, is critical to the development oforts 13, 1246–1257, November 10, 2015 ª2015 The Authors 1253
mechanical allodynia (Malmberg et al., 1997; Li et al., 2005;
Shumilla et al., 2005;Miraucourt et al., 2007).We therefore asked
whether the mechanical allodynia observed after ablation of PV
interneurons resulted from loss of inhibitory control of the
PKCg interneurons. Potentially relevant to this scenario is the
result of our immunofluorescence experiments indicating that
the percentage of PKCg neurons without apposition from PV
interneurons is significantly increased in the AAV-Saporin-
injected mice compared to control or AAV-GFP-injected mice
(Figure 7E). Additionally, the mean number of appositions is
significantly reduced after ablation of PV neurons. (Figure 7D).
Taken together, these findings suggest that in comparison to
control or AAV-GFP-injected mice, a greater number of PKCg
interneurons are disinhibited in the AAV-Saporin-injected mice.
We hypothesized that the loss of inhibitory control over PKCg
interneuron activity would enable these neurons to transfer
innocuous information to nociceptive circuits. Indeed, light
brushing of the hindpaw ipsilateral to the site of saporin injection
induced Fos expression in the superficial lamina of the dorsal
horn. No induction was evoked in the superficial laminae of con-
trol or AAV-GFP-injectedmice (Figure 7F). Finally, we speculated
that if the mechanical allodynia observed in the AAV-Saporin-
injected mice resulted from disinhibition of PKCg interneurons
(Li et al., 2005; Shumilla et al., 2005), then blocking the activity
of the PKCg interneurons should attenuate the allodynia.
To test this possibility, we recorded mechanical thresholds
20–30 min after intrathecal injection of gV5-3. Figure 7G
illustrates that inhibition of PKCg activity, in fact, significantly
reduced the mechanical allodynia produced in the saporin-
injected mice (Figure 7G). In contrast, injection of TAT peptide
alone did not attenuate the mechanical allodynia.
DISCUSSION
Sensory inputs from the periphery are processed by a complex
network of excitatory and inhibitory interneurons in the dorsal
horn prior to transmission to projection neurons and from there
to the brain (Figure 1). Our understanding of this processing is
incomplete, due in part to the heterogeneity of the interneurons.
For example, four non-overlapping subsets of inhibitory inter-
neurons have been identified, based on their expression of the
markers galanin, neuropeptide Y (NPY), neuronal nitric oxide
synthase (nNOS), and PV (Tiong et al., 2011). Immunohistochem-
ical experiments have established that noxious stimuli activate
the NPY, nNOS, and galanin, subsets of interneurons, with the
latter being also engaged by pruritic stimuli (Kardon et al.,
2014). The PV neurons, however, appear not to be activated
by noxious (and possibly not by pruritic) stimuli (Polga´r et al.,
2013a). Our results are the first to characterize the role of PV
neurons to the processing of sensory inputs and thus advance
our understanding of the organization of inhibitory circuits in
the dorsal horn.
Contribution of PV Interneurons to the Processing of
Somatosensory Inputs
We used pharmacogenetic tools to control the activity of PV
neurons in vivo. Our findings provide the first evidence of a highly
selective functional contribution of the PV neurons to the1254 Cell Reports 13, 1246–1257, November 10, 2015 ª2015 The Auprocessing of somatosensory information, and critical elements
of the circuits that are engaged by these neurons. Activity of
the PV neurons prevents innocuousmechanical inputs from acti-
vating nociceptive mechanical circuits but has no impact on the
transmission of noxious thermal inputs, highlighting their function
as modality-specific filters of sensory inputs. Increasing their
activity reducesmechanical allodynia in amousemodel of neuro-
pathic pain. The effect of PV neuron activation on mechanical
sensitivity is more pronounced in nerve-injured mice compared
to naive mice. This may be due to a near-saturation basal activity
of PVneurons under control conditions, anda reducedactivity af-
ter nerve injury. It follows that, in the setting of nerve injury, the net
effect of activating PV interneurons with CNO would be more
demonstrable. Thus, selectively increasing the activity of PV neu-
rons may be beneficial in the treatment of neuropathic pain.
Postsynaptic Targets of PV Interneurons
In the mouse dorsal horn, PV interneurons have an extensive
dendritic arborization in the rostro-caudal axis (Hughes et al.,
2012). Consistent with previous reports, we observed that PV
axons are largely limited to lamina IIi, occasionally extending
into lamina IIo, but they never reach lamina I. Furthermore, we
found that PV interneurons form synapses onto PKCg excitatory
interneurons, which populate lamina IIi and are implicated in
mechanical allodynia (Malmberg et al., 1997; Miraucourt et al.,
2007). The functional relevance of this synaptic connection
remained unknown. We showed that selective ablation of PV
neurons precipitated a mechanical allodynia comparable to
that produced by nerve injury and that was correlated with a
significant reduction in the number of appositions onto PKCg
interneurons. The disinhibition of PKCg interneurons is central
to the allodynia, as it was abolished by PKCg blockade. Taken
together, our findings illustrate how a functional interaction
between two distinct subsets of dorsal horn interneurons can
influence the flow of non-nociceptive information to deeper
laminae of the dorsal horn, while concurrently preventing access
to pain transmission circuits in the superficial dorsal horn. It was
recently reported that a newly identified subset of excitatory
interneurons, located mainly in lamina III and expressing the ve-
sicular glutamate transporter VGluT3, contribute to mechanical
allodynia (Peirs et al., 2015). These neurons receive low-
threshold mechanical inputs, and their activation with pharma-
cogenetic tools produces mechanical hypersensitivity (Peirs
et al., 2015). Whether PV interneurons also target these VGluT3
excitatory interneurons remains to be determined.
Contribution of PV Interneurons to Nerve-Injury-
Induced Mechanical Allodynia
Although loss of glycinergic tone is reported to contribute to me-
chanical allodynia in neuropathic pain models (Lu et al., 2013;
Miraucourt et al., 2007; Torsney and MacDermott, 2006; Foster
et al., 2015), the mechanisms responsible for the decrease
remain unclear. Previous studies reported that inhibitory inter-
neurons undergo apoptotic cell death following nerve injury
(Scholz et al., 2005). However, we found no change in the number
of PV interneurons after nerve injury. On the other hand, themean
number of appositions from PV nerve terminals onto PKCg
neurons somata is significantly lower after nerve injury. Whetherthors
this detachment is enough to explain the mechanical allodynia is
not known.
A decrease in excitatory inputs impinging on PV neurons can
decrease their inhibitory output. Consistent with this scenario,
Lu et al. (2013) showed that the amplitude of the Ab fiber-evoked
excitatory post-synaptic potentials (EPSPs) in glycinergic neu-
rons is significantly smaller in rats with nerve injury than in naive
rats. Furthermore, Leitner and colleagues (2013) reported that
peripheral nerve injury decreases the frequency of miniature
EPSPs in inhibitory interneurons, with no visible change in spine
density or morphology (Leitner et al., 2013). Changes in intrinsic
membrane properties of PV neurons could decrease their inhib-
itory function. Parvalbumin neurons are characterized by a high-
frequency firing rate and absence of spike frequency adaptation
(Hughes et al., 2012, 2013), a process requiring the recruitment
of small conductance, calcium-activated potassium (SK) chan-
nels (Bischop et al., 2012). By buffering the spike-mediated
calcium influx and preventing the calcium from activating SK
channels, PV could enable fast spiking (Franconville et al.,
2011; Eggermann and Jonas, 2012). In contrast, a decrease in
PV expression and a consequent buildup in intracellular calcium
would reduce the fast spiking of these interneurons, thus
reducing their inhibitory output. Either mechanism would lead
to a reduced inhibitory tone on PKCg interneurons. In fact, Lu
et al. demonstrated that peripheral nerve injury significantly
reduces the amplitude of glycinergic IPSPs in PKCg interneurons
compared to control rats, with a concomitant increase in trans-
mission failure rate and a decrease in paired-pulse ratio, sug-
gesting a presynaptic mechanism within the glycinergic neurons
(Lu et al., 2013).
It was recently reported that dynorphin-expressing GABAergic
interneurons, concentrated in lamina I and II, act as a gate to
prevent innocuous and noxious inputs from activating somato-
statin-expressing excitatory interneurons (Duan et al., 2014),
located in lamina II. These inhibitory neurons contribute to the
inhibition of itch signals from the periphery (Kardon et al.,
2014). They receive mainly polysynaptic Ab inputs (Duan et al.,
2014) as well as inputs from small-diameter afferents, evidenced
by their expression of Fos in response to noxious heat, capsa-
icin, pinch, and formalin (Polga´r et al., 2013b). Although the direct
synaptic target of these dynorphin-neurons is unknown, they are
linked to somatostatin interneurons. Given the morphology of
these neurons (Duan et al., 2014) and their dorso-ventral loca-
tion, they could be downstream targets of PKCg interneurons.
These putative circuits presumably occur upstream of the
mechanism described by De Koninck and colleagues, which
also contributes to decreased inhibition following peripheral
nerve injury. These authors demonstrated that nerve injury trig-
gers the synthesis and release of brain-derived neurotrophic fac-
tor (BDNF) from activated microglia. The latter binds its receptor
on lamina I neurons, resulting in a downregulation of the expres-
sion of the potassium-chloride co-transporter KCC2. The result
of this event is a shift in the chloride gradient of lamina I neurons,
which reduces the hyperpolarization effect of inhibitory synap-
ses (Cordero-Erausquin et al., 2005; Coull et al., 2003, 2005; Pre-
scott et al., 2014).
In conclusion, we have identified a subset of inhibitory inter-
neurons that normally prevents low threshold mechanoreceptiveCell Rep(tactile) inputs from engaging nociceptive circuits in the dorsal
horn of the spinal cord. In the absence of injury, these PV-con-
taining inhibitory interneurons contact PKCg-expressing excit-
atory interneurons and prevent their activation by innocuous
tactile stimuli. Importantly, our ablation data indicate that PV
interneurons exert a tonic inhibitory control over their targets.
By contrast, increasing the activity of PV interneurons alleviated
the mechanical allodynia in a mouse model of neuropathic pain.
Our results point to the PV interneurons as potential therapeutic
targets for the treatment of mechanical allodynia following nerve
injury.
EXPERIMENTAL PROCEDURES
Mouse Strains
All mouse strains used have previously been described. PV::cre, GFP, and
tdTomato reporter mice were obtained from Jackson Labs (stock numbers
008069, 007906, and 007914, respectively). TRPV1::cre mice were made by
A.I.B. (Cavanaugh et al., 2011b).
Immunohistochemistry
Immunohistochemistry on tissue sections and cell cultures were performed
using standard methods (see the Supplemental Experimental Procedures for
details).
Behavioral Assays
Experiments were conducted at room temperature. Mice were acclimatized
to their testing environment prior to all experiments. Experimenters were blind
to the genotype during testing. All experiments were performed on male 8- to
14-week-old mice, according to the Guidelines of the Animal Care Committee
of McGill University (see the Supplemental Experimental Procedures for
details).
See the Supplemental Experimental Procedures for details on virus injection
procedures, detection of appositions, and electron microscopy.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.09.080.
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